Palisade Bio Ownership | Who Owns Palisade Bio?
Palisade Bio Ownership Summary
Palisade Bio is owned by 17.25% institutional investors, and 82.75% retail investors. JHVIT Total Stock Market Index I is the top mutual fund, with 0.65% of its assets in Palisade Bio shares.
PALI Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Palisade Bio | 17.25% | - | 82.75% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2022 | 24 | 50.00% | 8,400,849 | 766.27% | 17 | 435.11% | 17 | 70.00% | 2 | 100.00% |
Jun 30, 2022 | 16 | -15.79% | 969,773 | 6.83% | 1 | 57.32% | 10 | - | 1 | -66.67% |
Mar 31, 2022 | 19 | -9.52% | 907,776 | -30.35% | 1 | 26.03% | 10 | -37.50% | 3 | 200.00% |
Dec 31, 2021 | 21 | 40.00% | 1,303,272 | 70.12% | 2 | 108.16% | 16 | 77.78% | 1 | -50.00% |
Sep 30, 2021 | 15 | -11.76% | 766,096 | -69.19% | 1 | 6.04% | 9 | -47.06% | 2 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
JHVIT Total Stock Market Index I | 9.92K | 0.65% | - |
Fidelity Extended Market Index | 6.45K | 0.47% | 449.00 |
Vanguard Institutional Extnd Mkt Idx Tr | 4.54K | 0.33% | - |
Bridgeway Ultra-Small Company | 4.10K | 0.30% | 4.10K |
NT Ext Equity Mkt Idx Fd - L | 2.12K | 0.15% | - |
Northern Trust Extended Eq Market Idx | 2.12K | 0.15% | - |
Fidelity Series Total Market Index | 1.52K | 0.11% | 1.39K |
NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 327.00 | 0.02% | 1.00 |
Fidelity Nasdaq Composite Index | 86.00 | 0.01% | - |
NT Ext Equity Mkt Idx Fd - NL | 12.00 | 0.00% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 28, 2024 | Williams Donald Allen | - | Buy | $4.86K |
May 24, 2024 | Finley John David | CEO, CFO, Director | Buy | $4.81K |
Feb 06, 2024 | Finley John David | CEO, CFO, Director | Buy | $4.69K |
Jan 31, 2024 | Finley John David | CEO, CFO, Director | Buy | $5.59K |
Jan 31, 2024 | Williams Donald Allen | - | Buy | $6.05K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | 2 | - |
2024 Q1 | 3 | - |
2023 Q4 | - | - |
2023 Q3 | 3 | 1 |
2023 Q2 | - | - |
PALI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools